| 29-Jun-2004 | S | Members of the Exchange are hereby informed that, Jagsonpal Pharmaceuticals Ltd. has fixed the
Record Date for the purpose of sub division of equity shares and bonus issue.
SUB- DIVIDED PAID-UP VALUE Rs.5/-
SUB-DIVIDED PAID-UP VALUE AND 20/07/2004 EX-BONUS DATE
Sub Division of existing equity shares from
every ONE equity share of Rs.10/- each into TWO equity shares of Rs.5/- each.
AND
THREE Bonus shares of Rs.5/- each for every ONE equity share of Rs.5/- each held.
The auction in the equity shares of Jagsonpal Pharmaceuticals Ltd. in Dematerialised Securities - Rolling Settlement Segment on 20/07/2004, 21/07/2004 and 22/07/2004 will be conducted as per face value of Rs.10/- each and on cum-bonus basis. Members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in
auction on the said dates.
The scrip will be No Delivery from 20/07/2004 to
28/07/2004 .
Note :-
i. Members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.5/- paid up w.e.f. 20.07.2004.
ii. ISIN No. INE048B01019 of Rs.10/- paid up will be discontinued w.e.f.20.07.2004 and the new
ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice. | 28-Jul-2004 | |
| 20-May-2024 | D | Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited (Standalone) Financial Results for the quarter and year ended March 31, 2024. In this regard, kindly find enclosed the following:
1.The Board recommended a dividend of Rs. 5/- (100%) per equity share for the financial year ended March 31, 2024. | 06-Sep-2024 | |
| 23-May-2023 | D | The Board of Directors at their meeting held today have recommended dividend of Rs. 5/- per equity share of face value of Rs. 5/- for the financial year ended March 31, 2023. The dividend shall be payable after it is approved by the shareholders at the 44th Annual General Meeting of the Company.
Pursuant to Regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has fixed Monday, August 21, 2023, as the Record Date for determining the entitlement of Members to dividend for the financial year ended March 31, 2023.
(As Per BSE Announcement Dated on 08.08.2023)
| 21-Aug-2023 | |
| 19-Oct-2021 | D | Board has approved the Unaudited Financial Results for the quarter and half year ended 30 September, 2021 . Further, the Board has also declared and approved an Interim Dividend @ 80% per Equity Shares of face value of Rs. 5/- each, i.e. Rs. 4/- per Equity Share.
The Interim Dividend shall be paid to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Monday, November 01, 2021 which is the Record Date fixed for the purpose.
The book closure will be from 02nd November, 2021 to 3rd November, 2021 for the purpose of Interim Dividend.
This is to inform that the Board of Directors has approved and declared an Interim Dividend @ 80% per Equity Shares of face value of Rs. 5/- each, i.e., Rs. 4/- per Equity Share in the Board Meeting held on Tuesday, 19 Day of October, 2021.
The Interim Dividend shall be paid to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the depositories as beneficial owners of the shares as on Monday, November 01, 2021 which is the Record Date/ Cut-off Date fixed for the purpose of Interim Dividend. | 29-Oct-2021 | |
| 30-Jun-2021 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2021, inter alia, has recommended dividend @ 20% per Equity Shares of face value of Rs. 5/- each, i.e. Re. 1/- per Equity Share. | 22-Sep-2021 | |
| 29-Jul-2020 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 29, 2020, inter alia, has recommended Dividend @ 10% on Equity shares of Rs. 5/- each. | 22-Sep-2020 | |
| 28-May-2019 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended Dividend @ 5% on Equity shares of Rs. 5/- each paid-up i.e. Rs. 0.25/- per share. | 20-Sep-2019 | |
| 30-May-2018 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2018, inter alia, have recommended dividend @ 2% on Equity Share of Rs. 5/- each paid-up i.e. Rs. 0.10/- per share. | 18-Sep-2018 | |
| 28-May-2017 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2017, inter alia, has recommended a dividend at the rate of Rs. 0.10 per equity share of Rs.5/- each.
AUDITED FINANCIAL RESULTS AND DECLERATION OF DIVIDEND
| 21-Sep-2017 | |
| 30-May-2016 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, has recommended a dividend at the rate of Rs. 0.10 per equity share of Rs. 5/- each, The dividend, if approved by the shareholders in the ensuing Annual General meeting scheduled to be held on September 30, 2016.
The Board Meeting commenced at 12.00 noon and concluded at 3.40 p.m. | 21-Sep-2016 | |
| 29-May-2015 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has recommended a final dividend of Rs. 0.10 per share (2%) subject to approval of the shareholders at the ensuing Annual General Meeting. | 21-Sep-2015 | |
| 24-Sep-2014 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended dividend of Rs. 0.50/- per Equity share of Rs. 5/- each. | 25-Sep-2014 | |
| 31-May-2013 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended dividend of Rs. 0.50/- per Equity Share of Rs. 5/- each. | 25-Sep-2013 | |
| 30-May-2012 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has recommended a dividend of Rs. 0.50 per equity shares on 2,61,98,000 Equity Shares of Rs. 5/- each for the year 2011-12. | 21-Sep-2012 | |
| 17-Aug-2011 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2011, inter alia, has recommended a dividend of Rs. 0.50 per equity shares on 2,61,98,000 Equity Shares of Rs. 5/- each for the year 2010-11. | 23-Sep-2011 | |
| 16-Aug-2010 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2010, inter alia, has recommended a Dividend of Rs. 0.50 per equity share on 2,61,98,000 equity shares of Rs. 5/- each for the year 2009-10. | 21-Sep-2010 | |
| 30-Jun-2009 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended a dividend of Rs 0.25 (Paise Twenty-five only) per equity share of Rs 5/- each for the year ended March 31, 2009. | 23-Sep-2009 | |
| 02-Sep-2008 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 01, 2008, inter alia, has recommended a dividend of Rs 0.10 only (Paisa Ten Only) on 2,61,98,000 Equity Shares of Rs 5/- each for the Financial Year ended March 31, 2008. | 24-Sep-2008 | |
| 27-Aug-2007 | D | Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 25, 2007, inter alia, has recommended Dividend of Rs 0.10 (Paise Ten only) on 2,61,98,000 equity shares of Rs 5/- each for the financial year ended March 31, 2007. | 21-Sep-2007 | |
| 24-Aug-2005 | D | 20% Dividend | 26-Sep-2005 | |
| 29-Jun-2004 | B | Members of the Exchange are hereby informed that, Jagsonpal Pharmaceuticals Ltd. has fixed the
Record Date for the purpose of sub division of equity shares and bonus issue.
SUB- DIVIDED PAID-UP VALUE Rs.5/-
SUB-DIVIDED PAID-UP VALUE AND 20/07/2004 EX-BONUS DATE
Sub Division of existing equity shares from
every ONE equity share of Rs.10/- each into TWO equity shares of Rs.5/- each.
AND
THREE Bonus shares of Rs.5/- each for every ONE equity share of Rs.5/- each held.
The auction in the equity shares of Jagsonpal Pharmaceuticals Ltd. in Dematerialised Securities - Rolling Settlement Segment on 20/07/2004, 21/07/2004 and 22/07/2004 will be conducted as per face value of Rs.10/- each and on cum-bonus basis. Members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in
auction on the said dates.
The scrip will be No Delivery from 20/07/2004 to
28/07/2004 .
Note :-
i. Members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.5/- paid up w.e.f. 20.07.2004.
ii. ISIN No. INE048B01019 of Rs.10/- paid up will be discontinued w.e.f.20.07.2004 and the new
ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice. | 28-Jul-2004 | 3:1 |
| 22-Nov-2024 | BC | We wish to inform you that Mr. Ashish Lakhotia has submitted the resignation as Chief Financial Officer of the Company & Key Managerial Personnel of the Company to pursue the opportunities outside th | 22-Jan-2025 | |
| 11-Nov-2024 | BC | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed postal notice for ordinary and special resolutions to approve the businesse | 11-Dec-2024 | |
| 19-Nov-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda | 21-Nov-2024 | |
| 16-Oct-2024 | BC | JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve (i) Unaudited Financial Results | 23-Oct-2024 | |
| 11-Oct-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday | 14-Oct-2024 | |